Literature DB >> 20493457

Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay.

Hirotomo Saitsu1, Jun Tohyama, Tatsuro Kumada, Kiyoshi Egawa, Keisuke Hamada, Ippei Okada, Takeshi Mizuguchi, Hitoshi Osaka, Rie Miyata, Tomonori Furukawa, Kazuhiro Haginoya, Hideki Hoshino, Tomohide Goto, Yasuo Hachiya, Takanori Yamagata, Shinji Saitoh, Toshiro Nagai, Kiyomi Nishiyama, Akira Nishimura, Noriko Miyake, Masayuki Komada, Kenji Hayashi, Syu-Ichi Hirai, Kazuhiro Ogata, Mitsuhiro Kato, Atsuo Fukuda, Naomichi Matsumoto.   

Abstract

A de novo 9q33.3-q34.11 microdeletion involving STXBP1 has been found in one of four individuals (group A) with early-onset West syndrome, severe hypomyelination, poor visual attention, and developmental delay. Although haploinsufficiency of STXBP1 was involved in early infantile epileptic encephalopathy in a previous different cohort study (group B), no mutations of STXBP1 were found in two of the remaining three subjects of group A (one was unavailable). We assumed that another gene within the deletion might contribute to the phenotype of group A. SPTAN1 encoding alpha-II spectrin, which is essential for proper myelination in zebrafish, turned out to be deleted. In two subjects, an in-frame 3 bp deletion and a 6 bp duplication in SPTAN1 were found at the initial nucleation site of the alpha/beta spectrin heterodimer. SPTAN1 was further screened in six unrelated individuals with WS and hypomyelination, but no mutations were found. Recombinant mutant (mut) and wild-type (WT) alpha-II spectrin could assemble heterodimers with beta-II spectrin, but alpha-II (mut)/beta-II spectrin heterodimers were thermolabile compared with the alpha-II (WT)/beta-II heterodimers. Transient expression in mouse cortical neurons revealed aggregation of alpha-II (mut)/beta-II and alpha-II (mut)/beta-III spectrin heterodimers, which was also observed in lymphoblastoid cells from two subjects with in-frame mutations. Clustering of ankyrinG and voltage-gated sodium channels at axon initial segment (AIS) was disturbed in relation to the aggregates, together with an elevated action potential threshold. These findings suggest that pathological aggregation of alpha/beta spectrin heterodimers and abnormal AIS integrity resulting from SPTAN1 mutations were involved in pathogenesis of infantile epilepsy. Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493457      PMCID: PMC3032058          DOI: 10.1016/j.ajhg.2010.04.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Polyalanine expansion of ARX associated with cryptogenic West syndrome.

Authors:  M Kato; S Das; K Petras; Y Sawaishi; W B Dobyns
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

2.  Independent movement, dimerization and stability of tandem repeats of chicken brain alpha-spectrin.

Authors:  Hideki Kusunoki; George Minasov; Ruby I Macdonald; Alfonso Mondragón
Journal:  J Mol Biol       Date:  2004-11-19       Impact factor: 5.469

3.  Properties of human red cell spectrin heterodimer (side-to-side) assembly and identification of an essential nucleation site.

Authors:  D W Speicher; L Weglarz; T M DeSilva
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 4.  Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin.

Authors:  Vann Bennett; Jane Healy
Journal:  Trends Mol Med       Date:  2007-12-20       Impact factor: 11.951

5.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

6.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

7.  A mutant alphaII-spectrin designed to resist calpain and caspase cleavage questions the functional importance of this process in vivo.

Authors:  Fleur Meary; Sylvain Metral; Chrystophe Ferreira; Dominique Eladari; Yves Colin; Marie-Christine Lecomte; Gaël Nicolas
Journal:  J Biol Chem       Date:  2007-03-20       Impact factor: 5.157

8.  Spectrin mutations cause spinocerebellar ataxia type 5.

Authors:  Yoshio Ikeda; Katherine A Dick; Marcy R Weatherspoon; Dan Gincel; Karen R Armbrust; Joline C Dalton; Giovanni Stevanin; Alexandra Dürr; Christine Zühlke; Katrin Bürk; H Brent Clark; Alexis Brice; Jeffrey D Rothstein; Lawrence J Schut; John W Day; Laura P W Ranum
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

9.  [Beta]IV-spectrin regulates sodium channel clustering through ankyrin-G at axon initial segments and nodes of Ranvier.

Authors:  Masayuki Komada; Philippe Soriano
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

10.  Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells.

Authors:  B M Riederer; I S Zagon; S R Goodman
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

View more
  54 in total

1.  Genetic testing in epilepsy: what should you be doing?

Authors:  Ingrid E Scheffer
Journal:  Epilepsy Curr       Date:  2011-07       Impact factor: 7.500

Review 2.  A Fresh Look at the Structure, Regulation, and Functions of Fodrin.

Authors:  Jamuna S Sreeja; Rince John; Dhrishya Dharmapal; Rohith Kumar Nellikka; Suparna Sengupta
Journal:  Mol Cell Biol       Date:  2020-08-14       Impact factor: 4.272

3.  Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Authors:  A R Paciorkowski; Y Shafrir; J Hrivnak; M C Patterson; M B Tennison; H B Clark; C M Gomez
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

Review 4.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

5.  Schwann cell spectrins modulate peripheral nerve myelination.

Authors:  Keiichiro Susuki; Alya R Raphael; Yasuhiro Ogawa; Michael C Stankewich; Elior Peles; William S Talbot; Matthew N Rasband
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

6.  The role of spectrin in cell adhesion and cell-cell contact.

Authors:  Beata Machnicka; Renata Grochowalska; Dżamila M Bogusławska; Aleksander F Sikorski
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-21

Review 7.  SPTAN1 encephalopathy: distinct phenotypes and genotypes.

Authors:  Jun Tohyama; Mitsuko Nakashima; Shin Nabatame; Ch'ng Gaik-Siew; Rie Miyata; Zvonka Rener-Primec; Mitsuhiro Kato; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

8.  Remodeling of the axon initial segment after focal cortical and white matter stroke.

Authors:  Jason D Hinman; Matthew N Rasband; S Thomas Carmichael
Journal:  Stroke       Date:  2012-12-11       Impact factor: 7.914

Review 9.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

10.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.